Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Substance Misuse

Dáil Éireann Debate, Thursday - 14 December 2017

Thursday, 14 December 2017

Ceisteanna (392, 393, 412, 413, 414, 417, 418, 419, 420, 421, 423, 425)

Billy Kelleher

Ceist:

392. Deputy Billy Kelleher asked the Minister for Health the number of HSE staff who have received training in 2017 on SAOR screening and brief intervention for problem alcohol and substance use. [53843/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

393. Deputy Billy Kelleher asked the Minister for Health the number of new patients that have received access to naxolone in 2017. [53844/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

412. Deputy Billy Kelleher asked the Minister for Health the number of adults who have been deemed appropriate for treatment for substance use in 2017; and the number who have received treatment within one calendar month, by LHO, in tabular form. [53863/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

413. Deputy Billy Kelleher asked the Minister for Health the number of children who have been deemed appropriate for treatment for substance use in 2017; and the number who have received treatment within one week, by LHO, in tabular form. [53864/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

414. Deputy Billy Kelleher asked the Minister for Health if he will report on the review of services in all CHOs in relation to the person-centred care planning processes of the drugs rehabilitation framework reassessment, key working and care planning. [53865/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

417. Deputy Billy Kelleher asked the Minister for Health if he will report on the HSE training programme for addiction staff, level 2 general practitioners and pharmacists in relation to buprenorphine naloxone and buprenorphine products. [53868/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

418. Deputy Billy Kelleher asked the Minister for Health the increase in addiction residential treatment beds and additional treatment episodes that has been provided in 2017. [53869/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

419. Deputy Billy Kelleher asked the Minister for Health if he will report on the development of integrated care pathways and referral pathways from the pharmacy needle exchange to other agencies. [53870/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

420. Deputy Billy Kelleher asked the Minister for Health the details of the expansion of other paraphernalia such as foil within the pharmacy needle exchange programme to allow persons the option of smoking rather than injecting. [53871/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

421. Deputy Billy Kelleher asked the Minister for Health the status of the guidelines and strategic statement on hidden harm. [53872/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

423. Deputy Billy Kelleher asked the Minister for Health the average waiting time from referral to assessment for opioid substitution treatment. [53874/17]

Amharc ar fhreagra

Billy Kelleher

Ceist:

425. Deputy Billy Kelleher asked the Minister for Health the average waiting time from opioid substitution assessment to exit from waiting list or treatment commenced. [53876/17]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 392, 393, 412 to 414, inclusive, 417 to 421, inclusive, 423 and 425 together.

As these are service matters, they have been referred to the Health Service Executive for attention and direct reply to the Deputy.

Barr
Roinn